Testing a cholesterol-regulating approach for diabetic eye disease

Diabetic retinopathy is eye damage caused by diabetes that can lead to vision loss, and current treatments don't fully prevent it. This trial is investigating whether a new approach targeting liver X receptors—proteins that help regulate cholesterol—could work better. Early research in animals suggests this treatment may stop diabetic retinopathy from developing or getting worse.

Studies have shown that abnormal cholesterol levels are linked to diabetic retinopathy getting worse, but we don't yet have a cure. This trial exists because laboratory research suggests this medication could address the root cause by restoring healthy cholesterol balance in the eye and reducing harmful inflammation.